Tokyo-based Astellas Pharma’s European subsidiary has announced that it has received marketing authorization from the Netherlands Medicines Evaluation Board (MEB) for Vesomni. The marketing authorization received for Vesomni is ...
Tags: Netherlands Meb, Medicine